These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 33587329)

  • 1. Pyroptosis executive protein GSDMD as a biomarker for diagnosis and identification of Alzheimer's disease.
    Shen H; Han C; Yang Y; Guo L; Sheng Y; Wang J; Li W; Zhai L; Wang G; Guan Q
    Brain Behav; 2021 Apr; 11(4):e02063. PubMed ID: 33587329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical indications for analysis of Alzheimer's disease CSF biomarkers.
    Engelborghs S
    Rev Neurol (Paris); 2013 Oct; 169(10):709-14. PubMed ID: 24016466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic inflammasome activation and pyroptosis associate with the progression of amnestic mild cognitive impairment and Alzheimer's disease.
    Rui W; Xiao H; Fan Y; Ma Z; Xiao M; Li S; Shi J
    J Neuroinflammation; 2021 Dec; 18(1):280. PubMed ID: 34856990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid Aβ1-40 improves differential dementia diagnosis in patients with intermediate P-tau181P levels.
    Slaets S; Le Bastard N; Martin JJ; Sleegers K; Van Broeckhoven C; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2013; 36(4):759-67. PubMed ID: 23666174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease.
    Leuzy A; Carter SF; Chiotis K; Almkvist O; Wall A; Nordberg A
    J Alzheimers Dis; 2015; 45(4):1077-88. PubMed ID: 25649653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New mechanism of nerve injury in Alzheimer's disease: β-amyloid-induced neuronal pyroptosis.
    Han C; Yang Y; Guan Q; Zhang X; Shen H; Sheng Y; Wang J; Zhou X; Li W; Guo L; Jiao Q
    J Cell Mol Med; 2020 Jul; 24(14):8078-8090. PubMed ID: 32521573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Decade of Cerebrospinal Fluid Biomarkers for Alzheimer's Disease in Belgium.
    Somers C; Struyfs H; Goossens J; Niemantsverdriet E; Luyckx J; De Roeck N; De Roeck E; De Vil B; Cras P; Martin JJ; De Deyn PP; Bjerke M; Engelborghs S
    J Alzheimers Dis; 2016 Aug; 54(1):383-95. PubMed ID: 27567807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical use of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative.
    Molinuevo JL; Blennow K; Dubois B; Engelborghs S; Lewczuk P; Perret-Liaudet A; Teunissen CE; Parnetti L
    Alzheimers Dement; 2014 Nov; 10(6):808-17. PubMed ID: 25150736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal Fluid P-Tau181P: Biomarker for Improved Differential Dementia Diagnosis.
    Struyfs H; Niemantsverdriet E; Goossens J; Fransen E; Martin JJ; De Deyn PP; Engelborghs S
    Front Neurol; 2015; 6():138. PubMed ID: 26136723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Molecular Correlations of GSDMD with Pyroptosis inAlzheimer's Disease.
    Song T; Chen Y; Li C; Yao Y; Ma S; Shang Y; Cheng J
    Comb Chem High Throughput Screen; 2024; 27(14):2125-2139. PubMed ID: 39099451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AD with subcortical white matter lesions and vascular dementia: CSF markers for differential diagnosis.
    Stefani A; Bernardini S; Panella M; Pierantozzi M; Nuccetelli M; Koch G; Urbani A; Giordano A; Martorana A; Orlacchio A; Federici G; Bernardi G
    J Neurol Sci; 2005 Oct; 237(1-2):83-8. PubMed ID: 15990115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid tau, Abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia.
    Jia JP; Meng R; Sun YX; Sun WJ; Ji XM; Jia LF
    Neurosci Lett; 2005 Jul 22-29; 383(1-2):12-6. PubMed ID: 15936505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CSF levels of the neuronal injury biomarker visinin-like protein-1 in Alzheimer's disease and dementia with Lewy bodies.
    Luo X; Hou L; Shi H; Zhong X; Zhang Y; Zheng D; Tan Y; Hu G; Mu N; Chan J; Chen X; Fang Y; Wu F; He H; Ning Y
    J Neurochem; 2013 Dec; 127(5):681-90. PubMed ID: 23800322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.
    Paterson RW; Slattery CF; Poole T; Nicholas JM; Magdalinou NK; Toombs J; Chapman MD; Lunn MP; Heslegrave AJ; Foiani MS; Weston PSJ; Keshavan A; Rohrer JD; Rossor MN; Warren JD; Mummery CJ; Blennow K; Fox NC; Zetterberg H; Schott JM
    Alzheimers Res Ther; 2018 Mar; 10(1):32. PubMed ID: 29558979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of microRNA-22 in regulating neuroinflammation in Alzheimer's disease.
    Han C; Guo L; Yang Y; Guan Q; Shen H; Sheng Y; Jiao Q
    Brain Behav; 2020 Jun; 10(6):e01627. PubMed ID: 32307887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of selenium, redox status and their association with plasma amyloid/tau in Alzheimer's disease.
    Krishnan S; Rani P
    Biol Trace Elem Res; 2014 May; 158(2):158-65. PubMed ID: 24682919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CSF biomarker profile and diagnostic value in vascular dementia.
    Paraskevas GP; Kapaki E; Papageorgiou SG; Kalfakis N; Andreadou E; Zalonis I; Vassilopoulos D
    Eur J Neurol; 2009 Feb; 16(2):205-11. PubMed ID: 19146641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine.
    Chiasserini D; Biscetti L; Farotti L; Eusebi P; Salvadori N; Lisetti V; Baschieri F; Chipi E; Frattini G; Stoops E; Vanderstichele H; Calabresi P; Parnetti L
    J Alzheimers Dis; 2016 Jul; 54(1):55-67. PubMed ID: 27447425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid Aβ
    Bayart JL; Hanseeuw B; Ivanoiu A; van Pesch V
    J Neurol; 2019 Sep; 266(9):2304-2311. PubMed ID: 31179518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.